Aurobindo Pharma announced that the United States Food and Drug Administration (US FDA) inspected Unit-II, an API manufacturing
facility, of Apitoria Pharma, a wholly owned subsidiary of the Company, situated at Gaddapotharam Village IDA, Jinnaram Mandal, Sanga Reddy District, Telangana from 23-27 September 2024.
facility, of Apitoria Pharma, a wholly owned subsidiary of the Company, situated at Gaddapotharam Village IDA, Jinnaram Mandal, Sanga Reddy District, Telangana from 23-27 September 2024.
The inspection closed with 10 observations. The observations are of procedural in nature and will be responded to within the stipulated time.
Powered by Capital Market – Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
First Published: Sep 30 2024 | 2:32 PM IST
